Bcel stock forecast.

Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25.12 analysts have issued twelve-month price objectives for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY ...The 360 Finance, Inc. stock price fell by -2.78% on the last day (Wednesday, 22nd Nov 2023) from $16.53 to $16.07. During the last trading day the stock fluctuated 4.68% from a day low at $15.81 to a day high of $16.55. The price has risen in 6 of the last 10 days and is up by 4.15% over the past 2 weeks.Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum.Atreca, Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Atreca, Inc. Stock | BCEL | US04965G1094

Price target. 1.93D CAD +1.58 +451.02%. The 7 analysts offering 1 year price forecasts for ENTHUSIAST GAMING HOLDINGS INC have a max estimate of 2.50 and a min estimate of 1.50.

See Atreca, Inc. (BCEL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business.

Atreca (BCEL) suspends the development of only pipeline candidate, ATRC-101, in clinical evaluation, as part of its business restructuring efforts and cuts headcount by 40%. The stock falls 37%.See ENTHUSIAST GAMING HOLDINGS INC stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 1.93 0.00 0.00%. The 7 analysts offering 1 year price forecasts for EGLX have a max estimate of — and a min estimate of —.The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ...12 analysts have issued twelve-month price objectives for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY ...

Patterson-UTI Energy Inc () Stock Market info Recommendations: Buy or sell Patterson-UTI Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Patterson-UTI Energy share forecasts, stock quote and buy / sell signals below.According to present data Patterson-UTI Energy's PTEN shares and potentially …

9.19M. AMZN. 146.74. +0.02%. 21.10M. New. View today's Atreca Inc stock price and latest BCEL news and analysis. Create real-time notifications to follow any changes in the live stock price.

In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.Li Auto Inc - ADR Stock Forecast, LI stock price prediction. Price target in 14 days: 44.695 USD. The best long-term & short-term Li Auto Inc - ADR share price ... BCEL forecast by analyst 3. Atreca stock fundamental checker 4. BCEL social sentiment 5. The Bright Future of Atreca Inc. Stock Forecast: Innovative Solutions and Strategic …Atreca Inc. Cl A analyst ratings, historical stock prices, earnings estimates & actuals. BCEL updated stock price target summary. Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...

Find the latest W&T Offshore, Inc. (WTI) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Science. Atreca Inc (NASDAQ:BCEL)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 1.24. At the close of trading, the stock’s price was $0.21. The BCEL share’s 52-week high remains $2.05, putting it -876.19% down since that peak but still an impressive 9.52% since price per share fell ...Atreca, Inc. (BCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Atreca Inc Cl A (BCEL) Company Description. Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism ... Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 28.00. The ...

Their VKTX share price targets range from $19.00 to $37.00. On average, they predict the company's stock price to reach $30.25 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price. View analysts price targets for VKTX or view top-rated stocks among Wall Street analysts.

Atreca Inc Cl A (BCEL) Company Description. Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism ... Dec 1, 2023 · Their VKTX share price targets range from $19.00 to $37.00. On average, they predict the company's stock price to reach $30.25 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price. View analysts price targets for VKTX or view top-rated stocks among Wall Street analysts. Find real-time ALLK - Allakos Inc stock quotes, company profile, news and forecasts from CNN Business.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 2.50. The median ...Stock Analyst Price Targets - Review. Analysts average stock forecasts to be materialized ratio is 4.17% with an average time for these price targets to be met of 0.17 days. Highest price target for BCEL is 5, Lowest price target is 1, average price target is 3. Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 14 …BCEL Stock Predictions, Articles, and Atreca Inc Cl A News From InvestorPlace From the Web 3 Penny Stocks to Catapult You Into the Millionaires’ Club By Omor Ibne Ehsan Jul 13, 2023 ...Coterra Energy Inc () Stock Market info Recommendations: Buy or sell Coterra Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Coterra Energy share forecasts, stock quote and buy / sell signals below.According to present data Coterra Energy's CTRA shares and potentially its market environment have …Patterson-UTI Energy Inc () Stock Market info Recommendations: Buy or sell Patterson-UTI Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Patterson-UTI Energy share forecasts, stock quote and buy / sell signals below.According to present data Patterson-UTI Energy's PTEN shares and potentially …

Qifu Technology (NASDAQ:QFIN) pays an annual dividend of $0.98 per share and currently has a dividend yield of 6.10%. QFIN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 28.16%. This payout ratio is at a healthy, sustainable level, below 75%.

Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin.

Atreca, Inc. Class A Common Stock (BCEL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ...ATRECA, INC. stock price forecast for further price development down to -100.00% (time horizon: 1 day) and price target of 0.00 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) ATRECA, INC. share price prediction for 2024-01-12 with daily closed price projectionsCompetitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ...April 06, 2023 — 09:55 am EDT. Written by Zacks Equity Research for Zacks ->. Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer ...The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...The Atreca Inc. stock price gained 5.36% on the last trading day (Friday, 17th Nov 2023), rising from $0.209 to $0.220. During the last trading day the stock fluctuated 9.33% from a day low at $0.210 to a day high of $0.230. The price has been going up and down for this period, and there has been a -16.59% loss for the last 2 weeks.Fiscal Q3 2023 ended 9/30/23. Get the latest Atreca Inc (BCEL) real-time quote, historical performance, charts, and other financial information to help you make more informed …April 06, 2023 — 09:55 am EDT. Written by Zacks Equity Research for Zacks ->. Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer ...

Stocks & ETFs, MFs & FOREX. AI Trend Prediction Engine. Stocks & ETFs, MFs & FOREXAt the time of writing, Atreca Inc [BCEL] stock is trading at $0.21, saw in change for the day. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The BCEL shares have gain 4.79% over the last week, with a monthly amount drifted -4.55%, andNov 6, 2023 · Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum. Instagram:https://instagram. publicly traded battery companiesvirgin galactivfvd etfwhat is best dental insurance plan The consensus price target of analysts on Wall Street is $2.00, which implies an increase of 89.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.00 and $2.00 respectively. As a result, BCEL is trading at a discount of -809.09% off the target high and -809.09% off the low. adp quotemusic for trading Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company’s product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-002 and VRDN ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Stock Trend Capital share forecasts, stock quote and buy / sell signals below. According to present data Stock Trend Capital's PUMP shares and potentially its market environment have been in bearish cycle last 12 months (if exists). c3 ai stoxk The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...The Atreca stock forecast for tomorrow is $ 0.213730, which would represent a -4.16% loss compared to the current price. In the next week, the price of BCEL is expected to decrease by -24.67% and hit $ 0.167988. As far as the long-term Atreca stock forecast is concerned, here’s what our ...Atreca Inc Cl A (BCEL) Company Description. Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism ...